stars 1 stars 2 stars 3

HepQuant develops non-invasive, quantitative tests that measure liver health. The HepQuant DuO Test enables healthcare providers to manage patients with liver diseases more effectively. The HepQuant DuO Test delivers information about liver cell function and portal-systemic shunting, attributes of liver disease that are associated with clinical outcomes. Results may be used by a physician in conjunction with clinical evaluation and other tests to aid in the decision to proceed with or defer invasive procedures, to monitor treatment response, or to predict disease progression and adverse outcomes, such as ascites, encephalopathy and variceal bleeding.

HepQuant Questions

The HepQuant annual revenue was $2 million in 2026.

Joellyn Enos is the Chief Commercial Officer (CCO) of HepQuant.

19 people are employed at HepQuant.

HepQuant is based in Denver, Colorado.

The NAICS codes for HepQuant are [541714, 541, 54171, 54, 5417].

The SIC codes for HepQuant are [87, 873].

Top HepQuant Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users